|
|
In silico bees
|
|
2
|
|
In silico biology
|
1998-
|
1
|
|
In silico biology : making the most of parallel computing /
|
|
2
|
|
In Silico Biology of Bone Regeneration Inside Calcium Phosphate Scaffolds / / Aurélie Carlier, Hans Van Oosterwyck and Liesbet Geris --
|
2013
|
1
|
|
In silico biology (Online)
|
1998-
|
1
|
|
In silico cell and tissue science
|
|
1
|
|
In Silico Cell Tissue Sci
|
|
1
|
|
In silico design of anticancer peptides / / Shailesh Kumar and Hui Li --
|
2017
|
1
|
|
In silico design of antimicrobial peptides / / Giuseppe Maccari, Mariagrazia Di Luca, and Riccardo Nifosì --
|
2015
|
1
|
|
In silico design of functional DNA constructs / / Alan Villalobos, Mark Welch, and Jeremy Minshull --
|
2012
|
1
|
|
In silico-directed evolution using CADEE / / Beat Anton Amrein, Ashish Runthala, and Shina Caroline Lynn Kamerlin
|
2019
|
1
|
|
In silico dreams : how artificial intelligence and biotechnology will create the medicines of the future
|
2021
|
1
|
|
In silico drug degradation prediction / / Mohammed A. Ali, Rachel Hemingway, and Martin A. Ott --
|
2018
|
1
|
|
In silico drug design : repurposing techniques and methodologies
|
2019
|
1
|
|
In silico drug discovery and design
|
2013
|
1
|
|
In silico drug discovery and design : theory, methods, challenges, and applications
|
2015
|
1
|
|
In Silico Evolution of Multi-scale Microbial Systems in the Presence of Mobile Genetic Elements and Horizontal Gene Transfer / / Ilias Tagkopoulos --
|
2011
|
1
|
|
In Silico Exploration of Therapeutics in Haematococcus pluvialis -- Part V
|
2023
|
1
|
|
In Silico Fingerprinting (ISIF): a user-friendly In Silico AFLP program / / Margot Paris and Laurence Després --pt. II.
|
2012
|
1
|
|
In silico genomics and proteomics : functional annotation of genomes and proteins
|
2006
|
1
|
|
In silico identification and characterization of protein-ligand binding sites / / Daniel Barry Roche and Liam James McGuffin --
|
2016
|
1
|
|
In silico identification of novel endo-siRNAs / / Andrew Schuster [and others] --
|
2015
|
1
|
|
In silico identification of novel G protein-coupled receptors / / Matthew N. Davies, David E. Gloriam, and Darren R. Flower --
|
2011
|
1
|
|
In silico identification of RNA modifications from high-throughput sequencing data Uuing HAMR / / Pavel P. Kuksa, Yuk Yee Leung, Lee E. Vandivier, Zachary Anderson, Brian D. Gregory, and Li-San Wang --
|
2017
|
1
|
|
In silico immunology
|
2007
|
1
|
|
In silico, in vitro and in vivo testing of biodevices --
|
2013
|
1
|
|
In Silico Infection of the Human Genome / / W.B. Langdon and M.J. Arno --
|
2012
|
1
|
|
In-silico Integration in Environmental Remediation
|
2023
|
1
|
|
In silico knowledge and content tracking / / Herman van Haagen and Barend Mons --
|
2011
|
1
|
|
In silico lead discovery
|
|
2
|
|
In silico medicinal chemistry : computational methods to support drug design
|
2015
|
1
|
|
In Silico Methods / / Alexander Amberg --
|
2013
|
1
|
|
In silico methods for analyzing mutagenesis targets / / Troy C. Messina --
|
2017
|
1
|
|
In Silico Methods for Carcinogenicity Assessment --
|
2016
|
1
|
|
In silico methods for predicting drug toxicity
|
|
2
|
|
In silico methods for toxicity prediction / / Robert D. Combes --
|
2012
|
1
|
|
In silico methods to identify exapted transposable element families / / LeeAnn Ramsay and Guillaume Bourque --
|
2016
|
1
|
|
In Silico Model for Developmental Toxicity: How to Use QSAR Models and Interpret Their Results --
|
2016
|
1
|
|
In Silico Modeling and Screening Studies of PfRAMA Protein: Implications in Malaria --
|
2021
|
1
|
|
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
|
2016
|
1
|
|
In silico modeling of drugs against coronaviruses : computational tools and protocols
|
2021
|
1
|
|
In-Silico Models as a Tool for the Design of Specific Treatments: Applications in Bone Regeneration / / Esther Reina-Romo, María José Gómez-Benito, Libardo Andrés González-Torres, Jaime Domínguez and José Manuel García-Aznar --
|
2012
|
1
|
|
In Silico Models for Acute Systemic Toxicity --
|
2016
|
1
|
|
In silico models for drug discovery
|
2013
|
1
|
|
In Silico Models for Ecotoxicity of Pharmaceuticals --
|
2016
|
1
|
|
In Silico Models for Hepatotoxicity --
|
2016
|
1
|
|
In Silico Models for Repeated Dose Toxicity (RDT): Prediction of the No Observed Adverse Effect Level (NOAEL) and Lowest Observed Adverse Effect Level (LOAEL) for Drugs --
|
2016
|
1
|
|
In silico oncology drug repositioning and polypharmacology / / Feixiong Cheng --
|
2018
|
1
|
|
In silico PCR analysis / / Bing Yu and Changbin Zhang --
|
2011
|
1
|
|
In silico PCR primer designing and validation / / Anil Kumar and Nikita Chordia --
|
2015
|
1
|
Add Marked to Bag
Add All On Page
Add Marked to My Lists
|